Researchers developed a living material approach that uses a strain of genetically engineered E.coli Nissle bacteria as a locally acting probiotic. The engineered bacteria produce a network of nanofibers that directly binds to mucus to fill inflamed areas like a patch, shielding them from gut microbes and environmental factors. This probiotic-based therapeutic strategy protected mice against the effects of colitis induced by a chemical agent and promoted mucosal healing. https://www.sciencedaily.com/releases/2019/12/191206112858.htm
A research conducted by Giannis Daras and Alexandros G. Dimakis, both students at the University…
An international team of scientists has released the Hubble Space Telescope's largest near-infrared image ever.…
Getting advertised for your work or brand is an excellent way to gain the public’s…
CEO Dave McComb, President of Semantic Arts, noted during a talk in 2021 that one…
The answer is a resounding YES! Artificial Intelligence is a stream of work that requires high-level…
The Metaverse is a platform that sounds like a sci-fi concept, but shockingly, it’s as…